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Abstract: A new type of freeze-drying microscope based upon time-domain 
optical coherence tomography is presented here (OCT-FDM). The 
microscope allows for real-time,  in situ  3D imaging of pharmaceutical 
formulations in vials relevant for manufacturing processes with a lateral 
resolution  of  <7  μm  and  an  axial  resolution  of  <5  μm.  Correlation  of 
volumetric structural imaging with product temperature measured during the 
freeze-drying cycle allowed investigation of structural changes in the 
product and determination of the temperature at which the freeze-dried cake 
collapses. This critical temperature is the most important parameter in 
designing freeze-drying processes of pharmaceutical products. 
©2011 Optical Society of America 
OCIS codes: (110.0180) Microscopy; (110.4500) Optical coherence tomography; (180.6900) 
Three-dimensional microscopy. 
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1. Introduction 
The development of biological drugs often requires product formulations  that must be 
lyophilized (freeze-dried) to produce stable products that can be stored in vials and 
reconstituted later for patient use. There are hundreds of biotechnology medicines and related 
products on the market and biotechnology drugs are the fastest growing segment of the 
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some of them are in late stage clinical trials [1]. Many new biotechnology drugs, including 
those used for the treatment of cancer are formulated and produced using the freeze-drying 
process. The most critical freeze-drying process design parameter is the temperature at which 
the product undergoes structural collapse during primary drying, which is called “collapse 
temperature” Tc [2]. Freeze-drying below Tc is necessary to ensure elegant appearance, low 
residual water content, and good storage stability and reconstitution characteristics. Therefore, 
accurate measurement of collapse is critical to freeze-drying process development. Since a 
1°C temperature increase during primary drying can result in 13% reduction in primary drying 
time, it is essential to optimize the primary drying temperature at a value close to (but not 
exceeding) Tc [3]. This could reduce the production-scale freeze-drying process by several 
days, resulting in significant operating costs savings and accordingly, lower costs of 
biotechnology drugs. 
Tc  is currently estimated using two techniques, light transmission freeze-drying 
microscopy (LT-FDM) and/or differential scanning calorimetry (DSC). LT-FDM is 
performed using a high vacuum cold stage. A thin film of solution (1-2 µl) is frozen between 
two glass surfaces and subjected to vacuum. The temperature is slowly increased to bring 
about sublimation typically at a ramp rate of 1°C/min followed by an equilibration time. As 
the temperature rises, viscous flow results in changes to the structure of the freeze-dried solid 
which may result in collapse of the freeze-dried cake. Thin films may have different ice 
nucleation rates, crystallization tendencies for solutes, frozen product structures, and drying 
rates as compared to bulk products in vials. Thus, current LT-FDM does not always 
accurately estimate Tc for freeze-drying in a container of practical significance, a vial. Both 
theoretical  and experimental evidence suggest that freeze-drying in a vial is sufficiently 
different than in a 2D sample used during LT-FDM that inefficient drying processes may be 
developed based upon LT-FDM. The difference in Tc determined using LT-FDM and that 
observed during freeze-drying in a vial is typically several degrees. This results in a 25% 
increase in drying time for every 2°C decrease in product processing temperature. Much 
larger discrepancies appear to occur in some protein formulations [4] and these differences 
may change as a function of formulation total solid content. A second technique, DSC, is used 
to determine the glass transition temperature of the maximally freeze concentrated solution 
(Tg′) and is also used as an estimation of Tc [2]. Tg′ is normally 1-3°C lower than Tc; however 
differences of 5-10°C have been reported [4]. Using Tg′ as an estimate for Tc would result in a 
primary drying temperature that is lower than required, also unnecessarily extending the 
freeze-drying time. 
Here we report on a new technique based on optical coherence tomography (OCT) to 
monitor changes in product structure while monitoring the product temperature to estimate Tc 
during freeze-drying in vials. This technique is intended to overcome the short-comings 
associated with determining Tc using DSC and LT-FDM by determining Tc in the same vial 
used during production operation. Moreover, the volumetric micron-level resolution and 3D 
imaging capabilities of OCT significantly enhance the current capabilities beyond the 
measurement of Tc to full exploration of the product response to temperature changes and 
imaging of structural changes and fine features of the freeze-drying process including ice 
nucleation and the freezing stage of lyophilization. 
OCT was first demonstrated in 1991 [5]. Since then, numerous applications of OCT for 
both biomedical and material science applications have emerged. Medical applications of 
OCT are continuously evolving and OCT has revolutionized the technology of superficial and 
epithelial tissue imaging. Visualization of cells, microorganisms, hair, brain and the interior of 
arteries have been reported with depth and transversal resolution of 1-15 µm [6–9]. There are 
two main types of OCT, namely time-domain OCT (TDOCT) and Fourier-domain OCT 
(FDOCT). In TDOCT, each pixel within a 3D scan is measured individually and the scan 
volume is obtained by scanning in all three Cartesian directions sequentially. In FDOCT all 
#157957 - $15.00 USD Received 9 Nov 2011; revised 1 Dec 2011; accepted 2 Dec 2011; published 7 Dec 2011
(C) 2011 OSA 1 January 2012 / Vol. 3,  No. 1 / BIOMEDICAL OPTICS EXPRESS  57pixels along an axial (depth) profile are measured simultaneously by Fourier transforming the 
spectrally resolved interference signal recorded either by a spectrometer (Spectral-domain 
OCT) [10–12] or by rapidly sweeping the source wavelength (Swept-source OCT) [9]. 
FDOCT has higher speed and an increased signal-to-noise ratio (SNR) compared to TDOCT 
[13,14]. There are, however, important limitations in FDOCT that still favor TDOCT as the 
option uniquely suited to certain applications. These limitations that are relevant for FDM are 
discussed below in the OCT design section. 
2. The OCT system 
The OCT system developed for the freeze-drying monitoring process is based on the time-
domain approach. Although, the FD approach has proven to provide significant increase in 
both speed and signal-to-noise-ratio (SNR), it has some limitations, related to lateral 
resolution and depth sensitivity, which are critical for freeze dry monitoring. Here we discuss 
in more detail these important parameters. 
Dynamic focusing. For Gaussian beams, the depth of focus and the beam waist (lateral 
resolution) are coupled. To achieve better lateral resolution one has to accept a short depth of 
focus. Conversely, if one requires a long depth of focus (2-3 mm), only a relatively poor 
lateral resolution (10-20 μm) can be achieved. Because the entire depth reflectivity profile is 
acquired simultaneously in FDOCT, the latter condition typically drives the design to prevent 
a large defocus along the axial profile (and concomitant worse lateral resolution and degraded 
image quality). This problem can be solved in TDOCT with dynamic focusing [15–17]. The 
in-focus region of the imaging beam and the coherence gate are scanned in depth 
simultaneously maintaining optimal focus and transverse resolution along the entire scan 
depth. 
Roll-off. In FDOCT, the reflectivity profile exhibits an inherent roll-off with depth due to 
the finite spectrometer pixel size (typically 10-15 µm). The Fourier transform of the CCD 
pixel rectangular function results in a sinc function in the spatial (depth) domain that 
decreases with depth. The result is an inherent reduction of the detected signal with depth of 
the order of 5-15 dB/mm, depending upon spectrometer design and alignment. TDOCT, on 
the other hand, has a constant sensitivity with depth as there is no intensity roll-off. 
Complex conjugate image. Fourier components outside the imaging window fold back 
into the imaging window in FDOCT. Sometimes their magnitude is small enough to not 
exceed the noise level, but in many cases, spurious reflections in the imaging system can bring 
significant unwanted artifacts into the imaging window making it difficult to distinguish 
between the real image and the complex conjugate image. These components do not appear in 
TDOCT allowing for the acquisition of images with reduced artifacts. Although there are 
methods to remove the complex conjugate image, they require additional hardware and signal 
processing techniques [18–24]. 
Depth penetration. The scattering properties of the sample reduce the detected signal with 
depth. Material science and biomedical applications typically involve highly scattering 
samples which limits the effective imaging depth. In addition to scattering, absorption also 
limits the effective imaging depth. Scattering decreases as the wavelength increases in the 
NIR but the absorption of water, the primary constituent of biological samples, increases. 
There are several low absorption windows at 800-900 nm and 1 µm and these spectral regions 
are preferred for applications where the sample has significant water content (like in 
ophthalmic applications where imaging is performed through more than 2 cm of water). In 
other applications involving dense scattering media, such as skin imaging however, the 1.3 
µm wavelength is generally preferred as the reduction in scattering overcomes the increase of 
water absorption over the 1-2 mm imaging depth. 
Because freeze-drying processes are extremely slow (durations of several hours to days) 
and the sample is stationary (as opposed to biological samples that often induce image motion 
artifacts), lateral resolution is more important than acquisition speed for this application. Also, 
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increasing the (source) signal level and SNR, as there are in, for example, ophthalmic 
applications with laser safety. Future experiments will be performed to ensure that the source 
intensity is not causing local heating within the frozen or freeze-dried cake. Based on the 
considerations described above, a TDOCT system with dynamic focusing at 1.3 µm was 
assembled for freeze-drying microscopy. 
A schematic of the TDOCT system is shown in Fig. 1. The light from a broadband 
superluminescent diode (SLD, Inphenix, Livermore, CA; center wavelength -  1275 nm, 
bandwidth – 105 nm) was split by a 90/10 fiber splitter with 90% of light going to the sample 
arm and 10% going to the reference arm of the interferometer. An acousto-optic modulator 
(AOM, Brimrose Corporation of America, Baltimore, MD) was used in the reference arm to 
create a carrier frequency by phase modulating the optical signal. The delay line (Fig. 2 (b)) in 
the reference arm consisted of a collimator, a retroreflector, a prism, and two mirrors for 
folding the optical path in a compact space. The collimator was mounted on a translation stage 
to allow for adjusting the length of the reference arm to overlap the coherence gate with the 
microscope objective focal plane. The retroreflector was mounted on a motorized translation 
stage (Thorlabs, Newton, NJ) together with the microscope objective for z-scanning and 
dynamic focusing (Fig. 2 (b)). In this way the microscope objective was translated to move 
the focal plane along the axial direction as the retroreflector was moved the same distance to 
maintain the sample and the reference arms matched in length for interference. Optical 
circulators (AC Photonics, Santa Clara, CA) were used in the sample and reference arms for 
optimum light collection (Fig. 1 and Fig. 2 (b)) and two polarization controllers (General 
Photonics, Chino, CA) were used to improve the interference efficiency (Fig. 2 (b)). The light 
back-reflected from both the reference and the sample arm was recombined with a 50/50 fiber 
splitter/combiner and the interference signal was detected with a balanced detector (Thorlabs, 
Newton, NJ) which rejects the background and the common-mode signal noise. 
 
Fig. 1. TDOCT setup. SLD –  1300 nm superluminescent diode; DET—balance detector; 
AOM—acousto-optic modulator; Circ—circulator; Col—collimator; R—retroreflector; Obj—
microscope objective; Scan—scanning optics; 90/10 and 50/50 fiber beamsplitters. 
Special attention was given to the dispersion mismatch between the sample and the 
reference arms. The mismatch was mainly due to the AOM which consists of two 1 cm long 
AMTIR crystals (Amorphous Materials Inc, Garland TX) with a refractive index of 2.55 at 1.3 
µm. Dispersion (variation of refractive index with wavelength) mismatch between reference 
and sample arms causes broadening  of the coherence peak and therefore a loss of axial 
resolution. To compensate for this dispersion mismatch a 1 cm thick AMTIR window was 
inserted in the free-space region of the sample arm. The light transmitted to and from the 
sample passed twice through the 1 cm AMTIR window compensating for the 2 cm of AMTIR 
in the AOM. 
The fiber optic components of the interferometer including the polarization controllers, the 
AOM, and the detector were placed on an 8”x12” breadboard (Fig. 2 (b)) that was mounted on 
four posts above the scanning optics. The scanning optics and the delay line occupied 
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the breadboard was used to mount the single-vial freeze dryer (not shown here). 
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Fig. 2. (a) Fiber-optic based interferometer and (b) the scanning optics. 
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Fig. 3. (a) Zemax optical design and (b) SolidWorks mechanical design. 
The scanning optics (Fig. 3) consisted of a collimator, a microscope objective (5x Plan 
Apo NIR Infinity-Corrected Objective, Mitutoyo, Japan), two galvanometers for x-y scanning 
(Thorlabs, Newton, NJ), and five mirrors for folding the optical path. Four of the mirrors were 
spherical and had two functions: first, they formed two stages of magnification to maintain the 
laser beam diameter small (2-5 mm) on the galvanometers’ mirrors and to expand it to 10 mm 
diameter to fill up the microscope objective pupil; and second, they ensured that the 
galvanometer mirrors were relayed to the objective pupil such that the scanning beam had a 
pivoting point at the objective entrance pupil. A large beam diameter at the objective pupil 
was needed to ensure the best performance of the objective (the smallest spot on the sample). 
The pupil beam diameter is inversely proportional to the beam waist in the focal plane, which 
represents the lateral resolution of the imaging system. A Zemax optical design was 
performed to optimize the performance of the optical system and a SolidWorks mechanical 
design was developed to guide the fabrication of the system (Fig. 3). 
The signal from the balanced detector was acquired by a high-speed digitizer board 
(National Instruments, Austin, TX) that also performed data processing. A LabVIEW 
interface was developed to control the OCT hardware, data acquisition and processing, real-
time image display and data storage. This included control of the galvanometer scanners for x-
y  scanning and of the motorized translation stage for z-scanning and dynamic focusing, 
synchronization of the galvanometers with the digitizer for data acquisition, and 
synchronization with the software controlling the single-vial freeze-dryer. An additional data-
acquisition board (National Instruments, Austin, TX) transferred the galvanometer signals and 
the synchronization signals to the freeze-drying hardware. 
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mode was used for sample alignment after the vial was introduced in the freeze-dryer chamber 
to bring the vial-product interface (inner vial surface) close to the side of the imaging window. 
This scan mode allowed for the determination of the optimum axial (z) limits of the 3D scan 
volume. 2) A second scan mode allowed for a single 3D scan volume in en-face mode (x-y 
first and then step axially). 3) The standard measurement scan mode allowed for scanning 3D 
volumes synchronized with the freeze-drying temperature control. The number of temperature 
steps (and therefore of the 3D volumes to be acquired) was set first, and then after each OCT 
volume scan a digital signal was sent to the freeze-dryer hardware control to step and hold the 
dryer shelf temperature at the next value. The OCT software waited until the freeze-dryer 
hardware control returned a signal indicating that the required temperature had been reached 
and then it continued with the next volume scan. 
OCT scan settings.  The scanning coordinate system had the x  and  y  axes in a plane 
perpendicular to the incident laser beam (en-face  cross-section) and the z  axis along the 
incident beam (depth into the sample). The scanning protocol was defined by: x-axis – fast 
scanning,  y-axis  –  slow scanning, and z-axis  –  the slowest scanning [25]. This approach 
relaxed the requirements on the speed of the dynamic focusing (along the z axis). In this 
manner, depth scanning and dynamic focusing could be implemented using a relatively slow 
motorized translation stage. 
One x-y frames took 0.75 s for scanning and 0.67 s for processing for a total of 1.42 s per 
frame and 282 s per volume. 
Lateral resolution. The theoretical lateral resolution (4λf/πD) given by the beam diameter 
D = 10 mm, focal length of the objective f = 40 mm and wavelength λ = 1.275 µm is 6.5 µm. 
The depth of focus (8λ/π*(f/D)
2) was estimated at 52 µm. The lateral resolution was measured 
using the standard USAF 1951 calibration target. Group 7 element 2 could be resolved giving 
a lateral resolution of 6.9 µm. 
Axial resolution.  The  theoretical  coherence  length  (2ln2λ
2/πΔλ)  given  by  the  central 
wavelength λ = 1.275 µm and the bandwidth Δλ = 105 nm (manufacturer specifications) is 6.8 
µm in air. However, the measured spectrum had a bandwidth of 65 nm giving a coherence 
length of 11 µm in air. Spectral narrowing may have been caused by the limited bandwidth of 
the optical components including fiber couplers, circulators, and most significantly, the AOM. 
The coherence length was measured by analyzing the depth profile of a mirror (full width at 
half maximum of the intensity coherence peak). The measured value of the coherence length 
was 13 µm. The axial resolution is defined as half of the coherence length and therefore, the 
measured value was 6.5 µm in air and 4.7 µm in the sample assuming an average refractive 
index of the sample or 1.38 (slightly larger than that of water due to the pharmaceutical 
formulation which could vary from sample to sample). 
3. The single vial freeze dryer 
A bench top single-vial freeze dryer (SVFD) was also designed and fabricated for this study. 
The main components of the freeze-dryer system were the: drying chamber, product shelf, 
heat transfer system, cooling system, condenser, vacuum pumping system, and process control 
instrumentation. One side of the SVFD contained an AR-coated glass window for OCT 
measurements. Detailed description of the SVFD and of the measurement results for various 
pharmaceutically representative formulations were presented elsewhere [26]. 
4. Results 
A preliminary test of the OCT-FDM system was performed by studying the collapse of a 5% 
sucrose solution in a 5 ml vial (0.75 ml of solution with about 4.5 mm product height in the 
vial). The shelf temperature was lowered from room temperature to −45°C and held for 45 
minutes to freeze the product and then it was raised to −40°C for 5 minutes. Vacuum was 
pulled on the SVFD and the temperature was raised by 2°C every 6 minutes to −10°C to 
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minutes. 
The frozen solution and the freeze-dried solid are visible using OCT-FDM as shown in 
Fig. 4. The reported temperatures are from the thermocouple located in the bottom center of 
the vial. At −28.9°C the solid structure begins to display gaps in the x-y cross section (en face 
view). In the z-y view the solid appears to be separating from the vial wall. In the video of the 
OCT-FDM (Media 1) for this formulation one can see complete separation of the freeze dried 
solid from the frozen solid, signifying complete collapse of the formulation. In Fig. 4 (a and 
b), Media 1 shows the collapse in the x-y direction while Media 2 shows the collapse in the z-y 
direction. The onset of collapse was determined to be −28.9°C, the temperature at which gaps 
in the dried cake were first observed. LT-FDM measurements of the same formulations were 
performed and the onset of collapse was observed at −32°C. Therefore, the Tc observed using 
OCT-FDM is ~3°C higher than measured using LT-FDM. This difference is consistent with 
the expected difference between freeze-drying in a vial and results obtained with the LT-FDM 
method [2]. A lyophilization cycle based on the Tc found by OCT-FDM rather than LT-FDM 
would result in a significant reduction in the primary drying time for this formulation (35-40% 
shorter). 
The OCT system acquires data in a 3D volume with a scan size – 0.75 mm / 4 mm / 1.5 
mm (x/y/z). To demonstrate the 3D visualization capability of OCT-FDM, Amira image 
processing software (Visage Imaging, Inc.) was used to compile a 3D display of the OCT 
data. The movie linked to Fig. 4 (c)  shows the 4D structural changes (time/temperature 
evolution of the 3D representation of the product) for 5% sucrose as described above. The 
movie indicates the shelf and product temperature for each frame (3D scan) and ends with a 
rotation of the 3D structure for better visualization of the collapsed structure. The fixed 
surface in the sucrose movie is the vial inner interface. 
 
Fig. 4. 2D cross-sections of 5% sucrose freeze-dried in a vial, (a)x-y view (Media 1), and (b) z-
y view (Media 2); (c) time evolution of the freeze-drying process in a 3D representation 
(Media 3). 
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A new type of freeze-drying microscope based on time-domain OCT was developed and 
demonstrated for the first time to measure Tc of product formulations freeze-dried in standard 
pharmaceutical vials. The OCT imaging system provided the means to measure a Tc that was 
predictive of freeze-drying characteristics of a batch of vials, as performed in a realistic 
manufacturing environment. This imaging tool has enormous advantages, particularly with 
formulations that can be freeze-dried above the Tc determined with LT-FDM without loss of 
product quality. Other investigators have reported freeze-drying near or above the Tc  as 
measured by LT-FDM with no evidence of macroscopic collapse of freeze-dried cake [27–
36]. Prior to our application of OCT to freeze-drying microscopy, Tc  measured for 
formulations using DSC or LT-FDM could not be assumed to be accurately predictive of 
freeze-drying in a vial or other large container of commercial significance. The Tc measured 
by OCT-FDM provides quantitative justification for freeze-drying above Tc as measured by 
LT-FDM. OCT-FDM provides an upper limit to the temperature at which a lyophilization 
cycle may be run without macroscopic product collapse. These data will help to reduce the 
time for primary drying and increase process efficiency for freeze dried products with more 
accuracy than current methods (LT-FDM, DSC). Literature data [4] suggest that the 
difference between collapse measured by LT-FDM and collapse that occurs in vials may be 
particularly large for protein formulations. As the importance of therapeutic proteins 
continues to grow, and the cost savings potentially resulting from “biosimilars” (i.e., 
“generic” therapeutic proteins) continues to receive emphasis from both Congress and the 
FDA, the benefits of OCT-FDM for product microstructure visualization and manufacturing 
process design will also assume greater importance. 
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